| PUBCHEM ID |
76956177
|
| UNII |
8WD52KIO2G
|
| Preferred Term |
RAZINODIL, (S)-
|
| CAS |
|
| INCHIKEY |
KUUKBTYSAHIXTN-KRWDZBQOSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
COc1cc(C(O[C@@H](CN2CCOCC2)CN2N=Nc(c(OC)c(c(OC)c3)OC)c3C2=O)=O)cc(OC)c1OC
|
| Total Surface Area |
433,76
|
| Relative PSA |
0,314
|
| TPSA |
139,18
|
| cLogS |
-3,198
|
| MW |
574,585
|
| cLogP |
1,5851
|
| H-Acceptors |
14
|
| H-Donors |
0
|
| Ro5 violations |
2
|
| Druglikeness |
-0,95647
|
| DrugScore |
0,135639675791608
|
| Mutagenic |
high
|
| Tumorigenic |
high
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,7736
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,2605
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,4497
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,5729
|
| Carcinogenicity (Three-class) |
Non-required
|
